A Multi-center Prospective Cohort Study Based on Peritoneal Dialysis Telemedicine-assisted Platform
NCT ID: NCT03571451
Last Updated: 2023-10-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
7000 participants
OBSERVATIONAL
2016-06-01
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Study of Efficacy and Safety of Automated PD in Urgent Start Dialysis
NCT03754361
Survival on Peritoneal Dialysis (PD) Versus Hemodialysis (HD) in China
NCT01413074
Cross-control Study on the Effect of Peritoneal Rest on Peritoneal Transport Function in Peritoneal Dialysis Patients
NCT05805813
Urgent-start Peritoneal Dialysis in ESRD Patients：A Multi-center Study
NCT02946528
Comparison of the Impact of Dialysis Treatment Type on Patient Survival
NCT00510549
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Of note, technique survival and patient survival in PD still need to be improved. Based on results from multi-center cohort studies, some prognostic factors have been explored and intervened in recent years. However, robust data from large samples on potential predictors pertaining to patients' clinical characteristics, and PD practice on clinical outcomes in the real world is still limited. This phenomenon calls an action on exploring novel risk factors of patient outcome, especially through national-level prospective cohort study.
The investigators are developing a national-level PD database by registering all patients receiving PD on PD TAP. The study is underway in 27 hospitals from 14 provinces located at 7 geographical regions (northwest, northeast, north, central, southwest, southeast and south) in China. National samples of PD units are recruited based on the availability of professional PD team who is willing participant and could regularly follow participants. Our study aims to enroll adult 7,000 patients with end stage renal disease receiving PD. Patients-, treatment- and telemedicine-level variables are collected at baseline and thus at 3-month intervals. PD practice surveys are collected at baseline. All-cause mortality and transfer to hemodialysis will be recorded as primary outcomes. Other clinical outcomes including infectious and non-infectious complications would be recorded. Apart from the above objectives, potential collaboration between PDTAP and local or international clinical research could develop ancillary studies with specific aims. Examples of key research and ancillary investigation proposed in PDTAP study are as follows: 1) Long-term effects of telemedicine on clinical outcomes of patients on PD: a propensity matched study, 2) Anemia, erythrocyte-stimulating agents, inflammation and the association with mortality in patients on PD, 3) The management of serum calcium, phosphate, and hyperparathyroidism and its relationship with mortality in patients on PD, 4) The prevalence of hypomagnesemia, and all-cause and cardiovascular mortality in patients on PD, 5) The prevalence, predictors, and outcomes of PD-related peritonitis, 6) Association between hemoglobin levels and serum albumin levels and mortality in diabetic and non-diabetic patients on PD, 7) Glucose absorption (measured as the difference between the amount of glucose in peritoneal dialysate absorbed into the peritoneal cavity in 24h and that measured in the 24h drained effluent) and its association with metabolic syndrome, cardiovascular events, and mortality in patients on PD. The follow-up will be continued until the end of the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* more than 14 years old
Exclusion Criteria
* loss to follow up without any outcomes recorded.
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Second Hospital of Hebei Medical University
OTHER
Army Medical University, China
OTHER
The First Affiliated Hospital of Zhengzhou University
OTHER
Hebei Medical University Third Hospital
OTHER
Peking University Shenzhen Hospital
OTHER
Handan Central Hospital
OTHER
Beijing Haidian Hospital
OTHER
People's Hospital of Qinghai Province
UNKNOWN
Cangzhou Central Hospital
OTHER
The Second Affiliated Hospital of Harbin Medical University
OTHER
Shengjing Hospital
OTHER
The Second Hospital of Anhui Medical University
OTHER
Peking University People's Hospital
OTHER
The First Affiliated Hospital of BaoTou Medical College
OTHER
The People's Hospital of Chuxiong Yi Autonomous Prefecture
UNKNOWN
Beijing miyun district hospital
UNKNOWN
Second Hospital of Shanxi Medical University
OTHER
People's Hospital of Gansu
UNKNOWN
Pingdingshan first people's Hospital
UNKNOWN
The first people's hospital of Xining
UNKNOWN
The First Hospital of Jilin University
OTHER
Cangzhou People's Hospital
OTHER
Taiyuan central hospital
UNKNOWN
People's hospital of Langfang
UNKNOWN
China Rehabilitation Research Center
OTHER_GOV
Dongzhimen Hospital, Beijing
OTHER
Department of Epidemiology and Biostatistics, School of Public Health, Peking University
UNKNOWN
Department of Statistics, Peking University First Hospital
UNKNOWN
Peking University First Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dong Jie
Director of Peritoneal dialysis center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The second affiliated hospital of Anhui Medical University
Hefei, Anhui, China
Peking University First Hospital
Beijing, Beijing Municipality, China
People's Hospital of Gansu Province
Lanzhou, Gansu, China
Peking University Shenzhen Hospital
Shenzhen, Guangdong, China
Cangzhou central hospital
Cangzhou, Hebei, China
People's hospital of Cangzhou
Cangzhou, Hebei, China
Handan Central Hospital
Handan, Hebei, China
People's hospital of Langfang
Langfang, Hebei, China
The second hospital of Hebei medical university
Shijiazhuang, Hebei, China
The third hospital of Hebei Medical University
Shijiazhuang, Hebei, China
The second affiliated hospital of Harbin Medical University
Harbin, Heilongjiang, China
Pingdingshan People's Hospital No.1
Pingdingshan, Henan, China
First affiliated hospital of Zhengzhou University
Zhengzhou, Henan, China
The first affiliated hospital of Baotou Medical College
Baotou, Inner Mongolia, China
The first hospital of Jilin University
Changchun, Jilin, China
Shengjing hospital affiliated to China Medical University
Liaoyang, Liaoning, China
People's Hospitel of Qinghai Province
Xining, Qinghai, China
The first people's hospital of Xining
Xining, Qinghai, China
Taiyuan central hospital
Taiyuan, Shanxi, China
The second hospital of Shanxi Medical University
Taiyuan, Shanxi, China
The People's Hospital of Chuxiong Yi Autonomous Prefecture
Chuxiong, Yunnan, China
Beijing Charity Hospital
Beijing, , China
Beijing dongzhimen Hospital
Beijing, , China
Beijing haidian hospital
Beijing, , China
Beijing miyun district hospital
Beijing, , China
Peking University People's Hospital
Beijing, , China
Xinqiao hospital of the Third Military Medical University
Chongqing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Tian-tian Ma, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Nan Zhao, MD
Role: primary
Xianzhao Zhang, MD
Role: primary
Wenxi Zhao, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Li X, Ma T, Hao J, Song D, Wang H, Liu T, Xu X, Dong J. The relationship between exercise and the occurrence of abdominal wall complications in patients on peritoneal dialysis. BMC Nephrol. 2025 Jul 15;26(1):389. doi: 10.1186/s12882-025-04317-7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PDTAP study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.